scholarly article | Q13442814 |
P50 | author | Panagis Filippakopoulos | Q28320317 |
Helen J Knowles | Q39272124 | ||
Linxin Li | Q62517934 | ||
Hannah Brunsdon | Q87700859 | ||
E. Elizabeth Patton | Q87700864 | ||
Kao Chin Ngeow | Q91165111 | ||
P2093 | author name string | Roman Fischer | |
Sarah Andrews | |||
Stefan Knapp | |||
Eiríkur Steingrímsson | |||
Katherine L B Borden | |||
Colin R Goding | |||
Laurent Volpon | |||
Georgina Berridge | |||
Sarah Picaud | |||
Zhiqiang Zeng | |||
Hans J Friedrichsen | |||
Richard Lisle | |||
P2860 | cites work | Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation | Q24528506 |
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness | Q24672631 | ||
Beyond BRAF: where next for melanoma therapy? | Q27006853 | ||
GSK-3-selective inhibitors derived from Tyrian purple indirubins | Q27642879 | ||
Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF | Q27675347 | ||
CRM1 is an export receptor for leucine-rich nuclear export signals | Q27860453 | ||
The receptor Msn5 exports the phosphorylated transcription factor Pho4 out of the nucleus | Q27936804 | ||
A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | Q27939311 | ||
Sumoylation of MITF and its related family members TFE3 and TFEB | Q28118825 | ||
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation | Q28140810 | ||
Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9 | Q28145594 | ||
Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor | Q28509336 | ||
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression | Q28591011 | ||
Identification of a signal for rapid export of proteins from the nucleus | Q29547742 | ||
A short amino acid sequence able to specify nuclear location | Q29547781 | ||
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma | Q29614282 | ||
Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle | Q29619289 | ||
Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS) | Q30486521 | ||
Leucine-rich nuclear-export signals: born to be weak | Q31151910 | ||
Cancer stem cells versus phenotype-switching in melanoma | Q34132378 | ||
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors | Q34132936 | ||
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis | Q34253185 | ||
Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner | Q34312986 | ||
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis | Q34338564 | ||
GSK3 takes centre stage more than 20 years after its discovery | Q34374129 | ||
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. | Q35062693 | ||
Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors | Q35071659 | ||
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. | Q35186010 | ||
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma | Q35596369 | ||
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma | Q35699278 | ||
Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1. | Q35968782 | ||
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development | Q36103651 | ||
Alternative promoter use in eye development: the complex role and regulation of the transcription factor MITF. | Q36512897 | ||
The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nucleation potential | Q36557590 | ||
Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes | Q36618911 | ||
Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. | Q36793719 | ||
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism | Q37378754 | ||
Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma. | Q37384015 | ||
MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function | Q37463551 | ||
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. | Q37618946 | ||
A localized Wnt signal orients asymmetric stem cell division in vitro | Q37664730 | ||
Coordinated activation of Wnt in epithelial and melanocyte stem cells initiates pigmented hair regeneration | Q38394850 | ||
Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. | Q38526803 | ||
Genetics of melanoma progression: the rise and fall of cell senescence | Q38589518 | ||
A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification. | Q38903238 | ||
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition | Q39067618 | ||
PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. | Q39193337 | ||
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma | Q39455824 | ||
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. | Q39600607 | ||
ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage | Q39622746 | ||
Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. | Q39715217 | ||
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma | Q39873596 | ||
Mitf-D, a newly identified isoform, expressed in the retinal pigment epithelium and monocyte-lineage cells affected by Mitf mutations. | Q40738107 | ||
Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling | Q40756889 | ||
Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance | Q40913428 | ||
Temperature-sensitive splicing of mitfa by an intron mutation in zebrafish | Q41732789 | ||
A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo | Q41884220 | ||
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature | Q42804978 | ||
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein | Q44500763 | ||
Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia | Q47860146 | ||
Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. | Q52169523 | ||
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes | Q59096765 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 37 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | E8668-E8677 | |
P577 | publication date | 2018-08-27 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export | |
P478 | volume | 115 |
Q91744934 | 3,4,5-Tri-O-Caffeoylquinic Acid Promoted Hair Pigmentation Through β-Catenin and Its Target Genes |
Q99565169 | Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor |
Q92254234 | MITF-the first 25 years |
Q90424217 | Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities |
Search more.